BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dhaunsi GS. Receptor-mediated selective impairment of insulin-like growth factor-1 activity in congenital disorders of glycosylation patients. Pediatr Res 2017;81:526-30. [PMID: 27089502 DOI: 10.1038/pr.2016.96] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Di Patria L, Annibalini G, Morrone A, Ferri L, Saltarelli R, Galluzzi L, Diotallevi A, Bocconcelli M, Donati MA, Barone R, Guerrini R, Jaeken J, Stocchi V, Barbieri E. Defective IGF-1 prohormone N-glycosylation and reduced IGF-1 receptor signaling activation in congenital disorders of glycosylation. Cell Mol Life Sci 2022;79:150. [PMID: 35211808 DOI: 10.1007/s00018-022-04180-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Westenfield K, Sarafoglou K, Speltz LC, Pierpont EI, Steyermark J, Nascene D, Bower M, Pierpont ME. Mosaicism of the UDP-Galactose transporter SLC35A2 in a female causing a congenital disorder of glycosylation: a case report. BMC Med Genet 2018;19:100. [PMID: 29907092 DOI: 10.1186/s12881-018-0617-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]